Trillium Therapeutics Inc. is an immuno oncology company developing innovative therapies for the treatment of cancer. The Company has two premier preclinical programs, SIRPaFc and a CD monoclonal antibody mAb , which target two key immunoregulatory pathways that tumor cells exploit to evade the host immune system. SIRPaFc is an antibody like fusion protein that blocks the activity of CD , a molecule that is upregulated on tumor cells in acute myeloid leukemia AML and numerous other malignancies. The CD mAb is a fully human monoclonal antibody that blocks the activity of CD , an immunosuppressive molecule that is overexpressed by many hematopoietic and solid tumors.
Quote | Trillium Therapeutics Inc. (NASDAQ:TRIL)
Last: | $18.44 |
---|---|
Change Percent: | 2.62% |
Open: | $17.92 |
Close: | $18.44 |
High: | $18.49 |
Low: | $17.83 |
Volume: | 25,934,077 |
Last Trade Date Time: | 11/16/2021 04:56:30 pm |
News | Trillium Therapeutics Inc. (NASDAQ:TRIL)
2023-03-19 07:43:18 ET Summary Two new Breakout Stocks for Week 12 with better than 10% short-term upside with ETFs and a Dow 30 Pick. Average cumulative returns for 2023 are +37.3% YTD. The Momentum Gauges® continue negative in bear funds from Mar 7th led by BNKD +65.7%. EGO...
Summary Two new Breakout Stocks for Week 46 with better than 10% short-term upside potential and a Dow 30 Pick. Average cumulative returns now up to +116.9% YTD. This week two picks gained 10% in less than a week with MAG +14.9% and CLNE +15.4% for total portfolio gains over 5%. ...
Message Board Posts | Trillium Therapeutics Inc. (NASDAQ:TRIL)
Subject | By | Source | When |
---|---|---|---|
Been a wild ride. 20 cents to a | alchemytrader | investorshub | 11/18/2021 5:59:13 PM |
Seeking alpha is reporting that the $PFE buyout | vinmantoo | investorshub | 11/16/2021 8:21:14 PM |
TRIL rose 2.7% after a Nasdaq delisting notice | LongRun8 | investorshub | 11/16/2021 6:04:58 PM |
TRIL has jumped from $18 to $18.45 | vinmantoo | investorshub | 11/16/2021 5:56:50 PM |
Thank you Leprecon777 that all makes sense then. | pipette | investorshub | 09/22/2021 9:03:56 PM |
News, Short Squeeze, Breakout and More Instantly...
Trillium Therapeutics Inc. Company Name:
TRIL Stock Symbol:
NASDAQ Market:
Trillium Therapeutics Inc. Website:
The emerging psychedelics industry is expanding rapidly across the globe. With research demonstrating promising therapeutic potential for substance...
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
CAMBRIDGE, Mass., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL) , a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, is pleased to announce...